Literature DB >> 33486692

Undiagnosed haemoglobinopathies among pregnant women attending antenatal care clinics in Pune, India.

Sumedha Dharmarajan1, Ameya Pawar2, Prajkta Bhide1, Anita Kar3,4.   

Abstract

Pregnant women with iron deficiency and those who are carriers of haemoglobinopathies present with anaemia of varying severity. There is no antenatal screening for haemoglobinopathies in India. The objective of this study was to determine the prevalence of undiagnosed haemoglobinopathy carriers in a random sample of pregnant women attending antenatal care clinics in Pune city, India. Biobanked DNA of 360 randomly selected pregnant women was genotyped for six common mutations and two common haemoglobin variants, HbS and HbE. Odds ratios (OR) with 95% confidence intervals were computed to determine association of carrier status with socio-demographic, haematological and clinical characteristics. The prevalence of undiagnosed haemoglobinopathy carriers was 6.3% (95% CI 4.2-9.4%) of which 3.3% (95% CI 1.9-5.7%) were beta thalassaemia carriers. There was an increased odds that beta thalassaemia carriers had moderate anaemia (OR 10.59, 95% CI 1.15-96.90). This study reveals the high prevalence of undiagnosed haemoglobinopathy carriers among pregnant women, indicating the need to immediately implement carrier screening and genetic counselling services across the country.

Entities:  

Keywords:  Anaemia; Beta thalassaemia; Haemoglobinopathy; India; Prevalence; Screening

Year:  2021        PMID: 33486692     DOI: 10.1007/s12687-021-00505-8

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  19 in total

1.  Epidemiology of beta-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat.

Authors:  Roshan Colah; Ajit Gorakshakar; Supriya Phanasgaonkar; Edna D'Souza; Anita Nadkarni; Reema Surve; Pratibha Sawant; Dilip Master; Ramesh Patel; Kanjaksha Ghosh; Dipika Mohanty
Journal:  Br J Haematol       Date:  2010-03-03       Impact factor: 6.998

Review 2.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

3.  Assessing the impact of screening and counselling high school children for beta-thalassaemia in India.

Authors:  Roshan Colah; Mariamma Thomas; Pramod Mayekar
Journal:  J Med Screen       Date:  2007       Impact factor: 2.136

4.  Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.

Authors:  Nongthombam Achoubi; Mohammad Asghar; Kallur Nava Saraswathy; Benrithung Murry
Journal:  Genet Test Mol Biomarkers       Date:  2012-10

5.  Falling prevalence of beta-thalassaemia and eradication of malaria in the Maldives.

Authors:  Naila Firdous; Stephen Gibbons; Bernadette Modell
Journal:  J Community Genet       Date:  2011-06-17

Review 6.  Population Screening for Hemoglobinopathies.

Authors:  H W Goonasekera; C S Paththinige; V H W Dissanayake
Journal:  Annu Rev Genomics Hum Genet       Date:  2018-05-11       Impact factor: 8.929

7.  Antenatal screening for identification of couples for prenatal diagnosis of severe hemoglobinopathies in surat, South gujarat.

Authors:  Dipal S Bhukhanvala; Smita M Sorathiya; Pratibha Sawant; Roshan Colah; Kanjaksha Ghosh; Snehalata C Gupte
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

Review 8.  The Global Burden of Anemia.

Authors:  Nicholas J Kassebaum
Journal:  Hematol Oncol Clin North Am       Date:  2016-04       Impact factor: 3.722

9.  Prevalence and hematological profile of β-thalassemia and sickle cell anemia in four communities of Surat city.

Authors:  Dipal S Bhukhanvala; Smita M Sorathiya; Avani P Shah; Ankur G Patel; Snehalata C Gupte
Journal:  Indian J Hum Genet       Date:  2012-05

10.  Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications.

Authors:  Prajkta Bhide; Pooja Gund; Anita Kar
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.